家庭用穿刺器具市場の機会分析と業界予測 2024-2033年

The home use lancing devices market was valued at $359.5 million in 2023 and is projected to reach $537.8 million by 2033, growing at a CAGR of 4.1% from 2024 to 2033.

家庭用穿刺器具市場は2023年に3億5,950万ドルと評価され、2024年から2033年まで4.1%のCAGRで成長し、2033年までに5億3,780万ドルに達すると予測されています。

A home use lancing device is a hand-held blood sampling instrument that measures blood glucose levels. It is a minimally invasive device that makes a small incision on the skin to draw out blood. The design of the device is similar to a pen that houses a small, sterile needle or lancet to puncture the skin, along with a trigger mechanism to release it. The key benefits of a home use lancing device include its convenience, cost-effectiveness, adjustable depth, and ease of use.

家庭用穿刺器具は、血糖値を測定する手持ち式採血器具です。皮膚に小さな切開を加えて血液を抜き出す、低侵襲の器具です。このデバイスの設計は、皮膚を穿刺するための小さな滅菌針またはランセットと、それを解放するためのトリガー機構を内蔵したペンに似ています。家庭用穿刺器具の主な利点には、利便性、費用対効果、調整可能な深さ、使いやすさが含まれます。

 Home Use Lancing Devices Market , by Type Report Highlights

Aspects	Details
Market Size By 2033	USD 537.8 Million
Growth Rate	CAGR of 4.1%
Forecast period	2024 – 2033
Report Pages	280
By Type	Standard Lancet Safety Lancet Others
By Application	Glucose Testing Cholesterol Testing Others
By Distribution Channel	Online Channel Offline Channel
By Region	North America  (U.S., Canada, Mexico) Europe  (France, Germany, Italy, Spain, UK, Rest of Europe) Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific) LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players	F. Hoffmann-La Roche Ltd, Ypsomed AG, Unilife Corporation, Owen Mumford Ltd, ARKRAY Inc, Terumo Corporation, Novo Nordisk A/S, Integra Lifesciences Corporation., LifeScan, Medtronic Plc